Cargando…

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes

OBJECTIVE: In the 2018 ATN framework, Alzheimer's neurodegenerative biomarkers comprised cerebrospinal fluid (CSF) total tau, (18)F‐fluorodeoxyglucose‐positron emission tomography, and brain atrophy. We aimed to assess the clinical outcomes of having discordant Alzheimer's neurodegenerativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu, Li, Hong‐Qi, Tan, Lin, Chen, Shi‐Dong, Yang, Yu‐Xiang, Ma, Ya‐Hui, Zuo, Chuan‐Tao, Dong, Qiang, Tan, Lan, Yu, Jin‐Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545611/ https://www.ncbi.nlm.nih.gov/pubmed/32949193 http://dx.doi.org/10.1002/acn3.51196

Ejemplares similares

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
por: Tan, Meng-Shan, et al.
Publicado: (2021)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function
por: Zhao, Li-Jing, et al.
Publicado: (2021)

Associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease: a Mendelian randomization study
por: Huang, Liang-Yu, et al.
Publicado: (2023)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

Multipredictor risk models for predicting individual risk of Alzheimer’s disease
por: Hou, Xiao-He, et al.
Publicado: (2023)

Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Hou, Xiao-He, et al.
Publicado: (2021)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia
por: Ma, Ya‐Hui, et al.
Publicado: (2020)

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study
por: Huang, Shu-Yi, et al.
Publicado: (2021)

Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
por: Zhao, Yong-Li, et al.
Publicado: (2022)

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases
por: Zhang, Cheng-Cheng, et al.
Publicado: (2017)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases
por: Xu, Wei, et al.
Publicado: (2020)

Plasma β(2)-microglobulin and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Huang, Yi-Ming, et al.
Publicado: (2023)

Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
por: Wang, Xiang-Xiang, et al.
Publicado: (2014)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Resveratrol as a Therapeutic Agent for Alzheimer's Disease
por: Ma, Teng, et al.
Publicado: (2014)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Genetically determined low income modifies Alzheimer’s disease risk
por: Wang, Rong-Ze, et al.
Publicado: (2021)

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease
por: Valenti, Denise A.
Publicado: (2011)

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
por: Wang, Zhi-Bo, et al.
Publicado: (2022)

Time spent in outdoor light is associated with the risk of dementia: a prospective cohort study of 362094 participants
por: Ma, Ling-Zhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rlprq4aq5ipmr9lh7elqp63c4